Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device User Fee Discussions Could Resurface During 107th Congress

This article was originally published in The Gray Sheet

Executive Summary

Medical device user fees could move back into legislative focus during the 107th Congress, Capitol Hill staffers report.

You may also be interested in...



User Fees In Administration's Budget Request Aimed At Third-Party Program

FDA's Center for Devices and Radiological Health is hoping that the most recent user fee proposal set forth in the administration's FY 2001 budget request might breathe some life into the agency's moribund 510(k) third-party review program.

Administration's Device User Fee Bill Has Yet To Find Sponsor In Congress

FDA device user fee legislation developed by the Clinton Administration and recently submitted in draft form to Congress is "dormant" but not yet dead, officials in the Office of Management and Budget say.

Device User Fee Proposal To Be Discussed By HIMA Board At Annual Meeting

A discussion on device user fees between a top health official in the Office of Management and Budget and the Health Industry Manufacturers Association board of directors suggests stepped-up efforts by the White House to generate support for its budget proposal and a potential willingness on the part of large device firms to reconsider their past opposition to user fees.

Related Content

UsernamePublicRestriction

Register

MT014464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel